2-Chloro-5-(Chloromethyl)-Thiazole Hydrochloride

2-Chloro-5-(Chloromethyl)-Thiazole Hydrochloride


    • Product Name 2-Chloro-5-(Chloromethyl)-Thiazole Hydrochloride
    • Alias 2-Chloro-5-(chloromethyl)thiazole hydrochloride
    • Einecs 643-173-9
    • Mininmum Order 1 gm
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    833675

    Chemical Formula C4H4Cl3NS·HCl
    Molecular Weight 220.97 g/mol
    Appearance Solid (usually white to off - white powder)
    Melting Point Typically in the range of 170 - 180 °C
    Solubility Soluble in polar solvents like water, methanol, ethanol
    Purity High - purity grades can reach over 98%
    Density N/A (as a solid, density values may be less commonly reported in this form)
    Boiling Point Decomposes before boiling
    Odor Odorless or very faint odor

    As an accredited 2-Chloro-5-(Chloromethyl)-Thiazole Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 250g of 2 - Chloro - 5 - (Chloromethyl) - Thiazole Hydrochloride in sealed chemical - grade bags.
    Shipping 2 - Chloro - 5 - (chloromethyl) - thiazole hydrochloride is a chemical. Shipping should be in well - sealed containers, following hazardous chemical regulations. Ensure proper labeling for safe and compliant transportation.
    Storage 2 - Chloro - 5 - (chloromethyl) - thiazole hydrochloride should be stored in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and contact with air. Store it separately from incompatible substances, like oxidizing agents. Ensure the storage area has good ventilation to minimize fume accumulation.
    Application of 2-Chloro-5-(Chloromethyl)-Thiazole Hydrochloride

    In continuous neonicotinoid campaigns at pilot scale, uncontrolled exotherms during the condensation of 2-chloro-5-chloromethylthiazole with 1-methyl-2-nitroguanidine frequently degrade the precious nitroguanidine reagent, producing dimeric byproducts that plate on reactor surfaces and necessitate abrasive cleaning cycles between batches. A 500‑L glass‑lined vessel equipped with a Pfaudler Cryo‑Lock jacket and cascade PID temperature control is charged with the thiazole intermediate, which is first isolated as the free base by slurrying the hydrochloride in deionized water (3.0 L/kg substrate), adjusting to pH 8.5–9.0 with 30 % aqueous sodium hydroxide, extracting into toluene, and distilling to ≤500 ppm residual water. The anhydrous 2-chloro-5-chloromethylthiazole is dissolved in dimethylformamide (4.0 L/kg) and combined with 1-methyl-2-nitroguanidine (1.00–1.05 molar equivalent) and finely milled anhydrous sodium carbonate (1.20 eq). Agitation is set to 150 rpm, the mass is heated to 60 °C at ≤1.0 °C/min, and the reaction temperature is held within a ±2 °C window for 6 h; jacket outlet temperature is locked at 65 °C to prevent localised overheating that triggers nitroguanidine degradation. Under these conditions conversion exceeds 98 % and the crude clothianidin precipitates upon drowning into ice‑water, affording purity of 97.0–99.2 % area by HPLC after vacuum drying at 50 °C. The process must rigorously exclude amine bases such as triethylamine, which quaternise the chloromethyl group prematurely, and any residual dimethylformamide moisture above 500 ppm that hydrolyses the electrophilic centre. The resulting clothianidin technical material (FAO Specification 700/TC/3, US EPA tolerance under 40 CFR §180.586) is formulated downstream as 600 g/L flowable suspension seed treatments (FS) or 50 % water‑dispersible granules (WG) for soil and foliar application.

    What Limits the Selectivity of Pd/Catalytic Hydrogenolysis to 2-Chloro-5-Methylthiazole?

    In the dedicated hydrogenation bay of fine‑chemical facilities manufacturing neonicotinoid intermediates, the conversion of 2-chloro-5-chloromethylthiazole to 2-chloro-5-methylthiazole is carried out in a 500 L stainless‑steel autoclave (Buchiglasuster BEP 630, magnetically driven stirrer, 60 bar MAWP) operated under a strictly limited hydrogen pressure window to suppress ring saturation. After neutralising the hydrochloride feed with sodium bicarbonate, the free base is dissolved in methanol (10 L/kg) and charged with 10 % palladium on carbon catalyst (type E101 NE/W, 2.0 % w/w relative to substrate). While conversion easily reaches >99 %, the critical quality attribute is selectivity toward the desired methylthiazole rather than the 4,5‑dihydrothiazole (thiazoline) over‑reduction product. Plant trials recorded in the site IQ/OQ dossier demonstrate that at 3.5 bar hydrogen and 45 °C the thiazoline level holds at 1.8–2.5 %, maintaining in‑process purity >96.5 %. Elevating pressure above 5.0 bar or raising temperature beyond 55 °C doubles the thiazoline fraction within 4 h, as shown in the multi‑lot trending table below. The hydrogenolysis intermediate is isolated by catalyst filtration through a 0.5 μm sintered‑metal candle, followed by vacuum distillation (70–75 °C at 20 mbar) to yield ≥99.0 % GC assay. This 2-chloro-5-methylthiazole stream feeds directly into the thiamethoxam synthesis block, where it is O‑methylated with dimethyl sulfate and condensed with N‑methyl‑N′‑nitroguanidine to afford thiamethoxam technical meeting FAO Specification 719/TC/3 and pre‑registered under REACH (EC 1907/2006). All operations are governed by ISO 9001:2015 quality management systems; the hydrogenation campaign is executed under an ATEX‑compliant zone classification with oxygen monitoring continuously below 2.0 %.

    10 % Pd/C loading (% w/w) H₂ pressure (bar) Conversion (%) Selectivity to 2-chloro‑5‑methylthiazole (%) Thiazoline byproduct (%)
    2.0 3.0 99.4 97.1 2.1
    2.0 3.5 99.5 96.8 2.4
    2.0 5.0 99.6 93.2 5.1
    1.5 5.0 98.8 90.7 7.4

    Screening of Phthalimide Substitution Conditions in Tetramisole Precursor Manufacture

    Production of levamisole hydrochloride active pharmaceutical ingredient relies on the conversion of 2-chloro-5-chloromethylthiazole into the key intermediate 2-chloro-5-phthalimidomethylthiazole under strictly controlled nucleophilic substitution conditions that avoid competitive hydrolysis. The hydrochloride is first neutralised in aqueous media as described earlier; the free base dissolved in N,N‑dimethylformamide (5.0 L/kg) is treated with potassium phthalimide (1.05 mol eq) in the presence of tetra‑n‑butylammonium bromide (0.5 mol %) at 80–85 °C for 8 h. In a 200 L Hastelloy C‑22 reactor equipped with a reflux condenser and bottom‑discharge valve, the heterogeneous suspension is maintained under a nitrogen blanket to keep oxygen levels below 0.5 %, protecting the chloromethyl group from oxidative degradation. After quenching with water and phase separation, the phthalimidomethyl intermediate is isolated at >96 % purity and subjected to hydrazinolysis with hydrazine monohydrate (1.5 eq) in methanol at reflux to liberate 2-chloro-5-aminomethylthiazole. This amine is then reacted with (R)‑styrene oxide in toluene to construct the tetramisole scaffold, and the enantiomeric resolution is performed with dibenzoyl‑D‑tartaric acid monohydrate. Table 2 summarises the influence of resolving agent stoichiometry and solvent composition on the optical purity of levamisole base, a critical parameter because the final API must meet Ph. Eur. monograph 01/2018:1677 (specific rotation −122° to −128° in water) and VICH GL18 residual solvent limits. The resolved levamisole is converted to its hydrochloride salt with ethereal HCl, crystallised from isopropanol/water, and dried under vacuum at 40 °C to deliver >99.5 % chemical purity and ≥99.5 % enantiomeric excess. Solvents that are protic or contain free amine groups are prohibited during the phthalimide stage, as they accelerate premature discharge of the chloromethyl electrophile before reaction with the nucleophile.

    Dibenzoyl‑D‑tartaric acid eq MeOH:H₂O (v/v) Crystallisation yield (%) Levamisole ee (%)
    0.55 85:15 48 99.2
    0.60 80:20 52 99.6
    0.65 75:25 54 99.4

    Maintaining anhydrous conditions below 50 ppm water is non‑negotiable when charging 2-chloro-5-chloromethylthiazole hydrochloride into quaternisation reactors for photographic dye production. In a typical sensitising‑dye campaign, the free base — generated immediately before use by neutralisation with 10 % sodium carbonate and extraction into nitromethane (dried over 3 Å molecular sieves) — is combined with an equimolar amount of 2-methylbenzothiazole iodide. The mixture is heated to gentle reflux (101–102 °C) under a calcium chloride guard tube, and the progress of the quaternisation is tracked by thin‑layer chromatography until disappearance of the alkyl iodide spot (typically 14–16 h). The resulting 2-chloro‑5-chloromethyl‑3‑methylbenzothiazolium salt is condensed directly with triethyl orthoformate in the presence of pyridine as catalyst to form the thiacarbocyanine chromophore, which is precipitated by addition of diethyl ether and recrystallised from methanol to meet photometric purity >99.0 % by absorbance ratio at 540 nm and 560 nm. The final dye crystals are employed in silver halide tabular‑grain emulsions as a green sensitizer, and the entire intermediate workflow complies with the purity criteria of ANSI/PIMA IT4.41‑1998 for photographic‑grade chemicals. Any ingress of moisture or use of protic co‑solvents leads to rapid hydrolysis of the chloromethyl group, generating thiazole‑methanol byproducts that shift the spectral sensitisation window and are rejected by quality‑control spectrophotometry.

    When 2-Chloro-5-Chloromethylthiazole Serves as a Cysteine-Targeting Covalent Warhead in Kinase Inhibitor Design

    In medicinal chemistry laboratories synthesising targeted covalent inhibitors against kinases harbouring a non‑catalytic cysteine, the chloromethylthiazole moiety is installed as a small, tuneable electrophile that alkylates the thiolate side chain without requiring a large exit‑vector scaffold. The compound, supplied as research‑grade hydrochloride with a purity of >98 % (GC‑FID), is liberated to the free base with N‑methylmorpholine in anhydrous dichloromethane immediately before use. A typical coupling sequence dissolves the peptide‑based inhibitor precursor (1.0 eq) in dry N,N‑dimethylformamide at 0.25 M, adds 1.2–2.0 eq of the chloromethylthiazole along with 3.0 eq of diisopropylethylamine, and stirs the homogeneous mixture at ambient temperature under argon for 16 h. The reaction is monitored by LC‑MS; completion is indicated when the starting peptide area falls below 2 %. Purification is performed by reverse‑phase semipreparative HPLC on a C18 column (250 × 21.2 mm) with a 0.1 % trifluoroacetic acid‑water/acetonitrile gradient, yielding the biotinylated or fluorophore‑tagged kinase conjugate at >95 % ultraviolet purity. All synthetic steps adhere to the quality principles of ICH Q11 for development‑stage drug substance, and the batch size is confined to <10 g to stay within safe exposure limits. The resulting covalent probe is immediately lyophilised and stored at −20 °C under nitrogen to preserve the electrophilic warhead for biochemical assay campaigns.

    Free Quote

    Competitive 2-Chloro-5-(Chloromethyl)-Thiazole Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The compound identified as 2-Chloro-5-(Chloromethyl)-Thiazole Hydrochloride (CAS RN: 131631-17-3) is supplied as a crystalline solid with a purity specification of ≥98.0% (HPLC, area normalization at 254 nm). Its molecular formula, C4H4Cl2NS·HCl, corresponds to a formula weight of 222.52 g/mol. The material exhibits a melting/ decomposition range of 145–150 °C (capillary method, uncorrected), and residual water content by Karl Fischer titration (ASTM E203) typically falls below 0.5 wt%. The hydrochloride salt form is deliberately selected to confer greater ambient stability and reduced lachrymatory potential compared to the free base, which undergoes rapid discoloration upon exposure to atmospheric moisture. Storage recommendations prescribe sealed containers under inert gas at 2–8 °C, with a retest interval of 12 months when unopened. For shipment in non-climate-controlled freight, data loggers recording temperature excursions above 25 °C for more than 48 hours indicate mandatory incoming assay verification.

    Does the Hydrochloride Salt Form Alter Reactivity at the Chloromethyl Site?

    The primary synthetic utility of this intermediate resides in the electrophilicity of the pendant chloromethyl moiety. Protonation of the thiazole nitrogen, as embodied in the hydrochloride salt, exerts a strong electron-withdrawing effect that increases the susceptibility of the –CH2Cl group toward nucleophilic displacement by roughly 1.5- to 2-fold relative to the free base in polar aprotic solvents. This difference has been quantified in model alkylation reactions using sodium azide in DMF at 23 °C: the pseudo-first-order rate constant for the hydrochloride salt is observed at 3.8 ± 0.2 × 10−3 s−1, compared to 2.1 ± 0.1 × 10−3 s−1 for the neutral species (in-house kinetic profiling, HPLC monitoring at 210 nm). Practitioners leveraging this enhanced reactivity in continuous-flow setups must account for a processing window narrowed to ±5 °C around a setpoint of −10 °C when coupling with highly nucleophilic thiolates; deviation beyond this bracket triggers oligomerization of the thiazole core, leading to viscous tars that foul microreactor channels with internal diameters below 0.5 mm.

    A critical operational boundary emerges where the reaction medium contains residual water above 0.1 vol%. At this threshold, the hydrochloride salt liberates trace HCl, catalyzing ring-opening hydrolysis to yield 2-chloro-5-(hydroxymethyl)thiazole and accelerating the formation of dimeric ether byproducts. On pilot-plant scale, this has manifested as yield losses of 8–12% per batch in unstirred tank reactors equipped with simple purge bubblers, whereas switching to a wiped-film evaporator for solvent drying and maintaining nitrogen headspace dew point below −40 °C restored yield to the 90–95% range. The salt form is incompatible with strong aqueous bases (pH > 10), which liberate the free base and trigger rapid precipitation of intractable gums that bind to glass-lined vessel walls and resist standard CIP protocols.

    Comparative Alkylation Performance Against Other C5-Chloromethyl Thiazoles

    A systematic evaluation of three C5-chloromethyl thiazole analogs—the subject hydrochloride, its free base analog 2-chloro-5-(chloromethyl)thiazole, and 5-(chloromethyl)thiazole hydrochloride—highlights process-critical distinctions. The table below abstracts data generated under identical conditions: alkylation of 4-methoxyphenol (guaiacol) in acetonitrile with 1.2 eq K2CO3 at reflux.

    Reactivity and impurity burden for C5-chloromethyl thiazole substrates in guaiacol alkylation
    Parameter 2-Chloro-5-(Chloromethyl)-Thiazole HCl 2-Chloro-5-(Chloromethyl)Thiazole (Free Base) 5-(Chloromethyl)Thiazole HCl
    Time to >95% conversion 3.2 h 6.8 h 4.1 h
    Assay of isolated product 98.4% (qNMR) 91.7% (contains 6.2% hydrolysis product) 96.1%
    Primary impurity at 1.0 RRT N,O-dialkylated dimer (0.8%) Hydroxymethyl analog (5.1%) Aldehyde oxidation product (1.4%)
    Filterability after aqueous workup Rapid (cake resistance 2 × 1010 m/kg) Slow, sticky filter cake Moderate

    The data underscore that the 2-chloro substituent provides an electronic deactivation that suppresses oligomerization prevalent with the unsubstituted 5-(chloromethyl)thiazole, while the hydrochloride salt mitigates the hydrolysis vulnerability of the free base. However, the salt’s advantage is partially offset by its generation of 1 equivalent of HCl during alkylation, necessitating at least 2 equivalents of inorganic base to maintain pH between 8–9 and prevent catalyst deactivation; in contrast, the free base requires only 1.05 equivalents, offering marginal reductions in aqueous waste volume—a factor assessed under E-factor calculations per ACS GCI Pharmaceutical Roundtable guidelines.

    When Substituting for 2-Bromo-5-(Chloromethyl)Thiazole in Palladium-Catalyzed Cross-Couplings

    Within the context of C–C bond formations at the 2-position, the 2-chloro group of this substrate is inert under standard Suzuki–Miyaura conditions using Pd(PPh3)4 (100 °C, aqueous Na2CO3/dioxane), whereas protocols developed for Suzuki coupling on 2-chlorothiazoles typically require Pd(OAc)2/XPhos catalyst systems operating at 120 °C under microwave irradiation. This differential reactivity permits orthogonal functionalization: the chloromethyl handle can be displaced by morpholine at 0 °C without disturbing the 2-chloro moiety, enabling sequential derivatization strategies that are not achievable with the more labile 2-bromo or 2-iodo analogs. The processing limit is defined by catalyst loading: below 0.5 mol% Pd, significant hydrodechlorination of the thiazole ring occurs, generating 5-substituted thiazole contaminants that co-crystallize with the target product and resist removal by recrystallization from ethanol/water mixtures.

    Moving to industrial-scale hydrogenation for synthesis of 2-chloro-5-(aminomethyl)thiazole derivatives, the hydrochloride salt is poorly suited for direct reductive amination because the high chloride ion concentration poisons carbon-supported platinum and palladium catalysts at rates exceeding 0.05 mg Cl⁻ per m² catalyst surface. Pre-treatment with propylene oxide to scavenge HCl, or switching to the free base, restores catalyst lifetime to over 15 turnovers before activity degrades below 80% of initial rate. In a manufacturing campaign spanning 8 batches of 50 kg each, the decision to use the hydrochloride salt with an in-line HCl scavenger versus pre-isolation of the free base resulted in a 14% reduction in overall cycle time but introduced an additional filtration step that increased operator exposure risk to Grade 3 sensitizing agents, requiring engineering controls as outlined in Control of Substances Hazardous to Health (COSHH) assessments.

    Specifications, Handling, and Integrated Safety Boundaries

    Release specifications and test methods for 2-Chloro-5-(Chloromethyl)-Thiazole Hydrochloride
    Attribute Limit Test Method
    Assay (anhydrous basis) 98.0–102.0% HPLC, USP 〈621〉, C18 column, 0.1% TFA in H2O/MeCN gradient
    Water content ≤ 0.5% ASTM E203 (Karl Fischer, coulometric)
    Residual solvents (MeOH, EtOAc, hexane) Class 2/3 per ICH Q3C GC-FID, USP 〈467〉 Procedure A
    Sulfated ash ≤ 0.2% USP 〈281〉
    Chloride content (ionic) 15.5–16.5% w/w Metrohm ion chromatography, suppressed conductivity
    Appearance White to off-white crystalline powder Visual against white/black background
    Heavy metals (Pb, As, Cd, Hg) ≤ 10 ppm total ICP-MS, ICH Q3D Option 1

    The material is classified under REACH as a skin corrosive (Category 1B) and respiratory sensitizer (Category 1). Processing vessels must be fabricated from borosilicate glass, PTFE, or Hastelloy C-276; carbon steel and aluminum are incompatible due to pitting corrosion in the presence of trace HCl vapor. All transfers at scale above 1 kg require local exhaust ventilation with a capture velocity of 0.5 m/s measured at the opening of the containment hood, as validated per ANSI/AIHA Z9.5. For airfreight, IATA Dangerous Goods Regulations classify the compound under UN 2923, Corrosive solid, toxic, n.o.s., Packing Group II, with a maximum net quantity of 15 kg per package on passenger aircraft.

    Vulnerability in Multi-Kilo Diazotization and Azide Workup Sequences

    Attempts to use this intermediate in telescoped sequences where the chloromethyl group is converted to an azide followed by Cu-catalyzed azide–alkyne cycloaddition (CuAAC) present a thermal hazard not apparent from DSC screening alone. Accelerating rate calorimetry (ARC) conducted in accordance with ASTM E1981 on the isolated azide derivative—generated within 1 hour at 25 °C using 1.1 eq NaN3—shows an onset of self-accelerating decomposition at 82 °C with a maximum self-heat rate exceeding 120 °C/min. The critical storage mass at ambient temperature, calculated via Frank-Kamenetskii modeling, imposes a maximum container diameter of 12 cm for the neat azide. As a consequence, the hydrochloride starting material is routed through the azide as a non-isolated intermediate in dilute solution (concentration < 0.3 M) and quenched immediately with the alkyne coupling partner. This approach, while robust at 200-g reaction calorimeter scale, required an over 18-month development period to scale to a 100-L Hastelloy reactor, where the heat removal capacity of the jacket (overall heat transfer coefficient ~250 W/m²·K) was marginally adequate to handle the exotherm of azide formation without crossing the autocatalytic decomposition envelope.

    Where process intensification is pursued through continuous flow, the solid hydrochloride is dissolved in acetonitrile (2 volumes) and metered into an aqueous azide stream via a Coriolis mass flow controller. The critical residence time in the azide formation zone is 18 seconds at 20 °C; any extension beyond 30 seconds triggers precipitation of the unstable azide that clogs the reactor’s static mixer elements. This narrow operating window demands redundant quench-injection systems and an interlock that diverts flow to a waste quench vessel upon detecting a pressure rise of > 0.3 bar across the reactor block. The synthesis of the advanced intermediate, 2-chloro-5-((4-phenyl-1H-1,2,3-triazol-1-yl)methyl)thiazole, ultimately achieved a 78% isolated yield at a throughput of 1.2 kg/day using a Corning Advanced-Flow reactor, a figure that represents a 22% improvement over batch mode, primarily due to the elimination of azide hold points.

    Differentiation from 2,4-Dichloro-5-(Chloromethyl)Thiazole in Heterocycle Assembly

    A common structural analog encountered in medicinal chemistry programs is 2,4-dichloro-5-(chloromethyl)thiazole. The additional chlorine at the 4-position introduces a regio-determining block that alters subsequent amination selectivity. For the 2-chloro-5-(chloromethyl) variant described herein, aminolysis with secondary amines (e.g., piperidine) at 0 °C proceeds exclusively at the chloromethyl site without competition at C-2, as confirmed by NOESY NMR; the 2,4-dichloro derivative, under identical conditions, yields a 3:1 mixture of 5-aminomethyl to 2-amino-substituted isomers, necessitating low-temperature fractional crystallization. The subject hydrochloride thus serves as a higher-specificity building block when late-stage C-2 functionalization via metal-mediated coupling is planned after installation of the C-5 amine. In terms of supply chain, the 2-chloro-5-(chloromethyl)thiazole core is typically manufactured via chlorination of the corresponding methylthiazole using sulfuryl chloride, whereas the 2,4-dichloro congener requires an additional Vilsmeier-type step that elevates cost by approximately 40% and increases the residual sulfur content (below 50 ppm per total sulfur analysis by UV fluorescence per ASTM D5453) being a key purity differentiator for sensitive downstream catalytic steps.